- Report
- April 2021
China
From €2495EUR$2,600USD£2,079GBP
- Report
- January 2022
- 110 Pages
Global
From €4558EUR$4,750USD£3,798GBP
- Report
- October 2023
- 116 Pages
Global
From €3500EUR$3,907USD£3,019GBP
- Report
- March 2025
- 50 Pages
Global
From €2543EUR$2,650USD£2,119GBP
Ambroxol Hydrochloride is a mucolytic drug used in the treatment of respiratory diseases. It is used to reduce the viscosity of mucus and facilitate its removal from the respiratory tract. It is commonly used to treat conditions such as bronchitis, chronic obstructive pulmonary disease (COPD), and asthma. Ambroxol Hydrochloride is available in various forms, including tablets, syrups, and inhalers. It is also used in combination with other drugs to treat respiratory infections.
Ambroxol Hydrochloride is a widely used drug in the respiratory drugs market. It is used to treat a variety of respiratory conditions, and its efficacy and safety have been well established. It is also cost-effective and widely available.
Some companies in the Ambroxol Hydrochloride market include GlaxoSmithKline, Merck, Pfizer, Sanofi, and Sun Pharmaceuticals. Show Less Read more
